Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $22.0B |
| FY2017, ended Dec 31, 2017 | $23.9B |
| FY2018, ended Dec 31, 2018 | $22.3B |
| FY2019, ended Dec 31, 2019 | $30.8B |
| FY2020, ended Dec 31, 2020 | $31.6B |
| FY2021, ended Dec 31, 2021 | $39.7B |
| FY2022, ended Dec 31, 2022 | $47.2B |
| FY2023, ended Dec 31, 2023 | $38.0B |
| FY2024, ended Dec 31, 2024 | $34.3B |
| FY2025, ended Dec 31, 2025 | $36.9B |
| Trailing 12 months to Jun 28, 2026 (through Q2 FY2026) | $36.0B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $7.44B |
| FY2017, ended Dec 31, 2017 | $7.52B |
| FY2018, ended Dec 31, 2018 | $7.79B |
| FY2019, ended Dec 31, 2019 | $7.99B |
| FY2020, ended Dec 31, 2020 | $8.15B |
| FY2021, ended Dec 31, 2021 | $8.97B |
| FY2022, ended Dec 31, 2022 | $10.4B |
| FY2023, ended Dec 31, 2023 | $11.2B |
| FY2024, ended Dec 31, 2024 | $11.2B |
| FY2025, ended Dec 31, 2025 | $11.7B |
| Trailing 12 months to Jun 28, 2026 (through Q2 FY2026) | $12.2B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $720M | $744M |
| FY2017, ended Dec 31, 2017 | $783M | $992M |
| FY2018, ended Dec 31, 2018 | $1.18B | $1.27B |
| FY2019, ended Dec 31, 2019 | $1.15B | $1.45B |
| FY2020, ended Dec 31, 2020 | $1.28B | $1.26B |
| FY2021, ended Dec 31, 2021 | $1.48B | $1.59B |
| FY2022, ended Dec 31, 2022 | $1.64B | $1.81B |
| FY2023, ended Dec 31, 2023 | $1.86B | $1.55B |
| FY2024, ended Dec 31, 2024 | $2.22B | $1.93B |
| FY2025, ended Dec 31, 2025 | $883M | $1.82B |
| Trailing 12 months to Jun 28, 2026 (through Q2 FY2026) | $1.49B | $2.23B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $297M |
| FY2017, ended Dec 31, 2017 | $380M |
| FY2018, ended Dec 31, 2018 | $588M |
| FY2019, ended Dec 31, 2019 | $493M |
| FY2020, ended Dec 31, 2020 | $1.14B |
| FY2021, ended Dec 31, 2021 | $329M |
| FY2022, ended Dec 31, 2022 | $464M |
| FY2023, ended Dec 31, 2023 | $402M |
| FY2024, ended Dec 31, 2024 | $731M |
| FY2025, ended Dec 31, 2025 | $926M |
| Trailing 12 months to Jun 28, 2026 (through Q2 FY2026) | $791M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.98B |
| FY2017, ended Dec 31, 2017 | $2.92B |
| FY2018, ended Dec 31, 2018 | $4.46B |
| FY2019, ended Dec 31, 2019 | $4.27B |
| FY2020, ended Dec 31, 2020 | $4.60B |
| FY2021, ended Dec 31, 2021 | $5.03B |
| FY2022, ended Dec 31, 2022 | $4.79B |
| FY2023, ended Dec 31, 2023 | $4.81B |
| FY2024, ended Dec 31, 2024 | $5.10B |
| FY2025, ended Dec 31, 2025 | $5.40B |
| Trailing 12 months to Jun 28, 2026 (through Q2 FY2026) | $5.61B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 5.4% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 212M |
| FY2017, ended Dec 31, 2017 | 210M |
| FY2018, ended Dec 31, 2018 | 209M |
| FY2019, ended Dec 31, 2019 | 210M |
| FY2020, ended Dec 31, 2020 | 207M |
| FY2021, ended Dec 31, 2021 | 205M |
| FY2022, ended Dec 31, 2022 | 204M |
| FY2023, ended Dec 31, 2023 | 204M |
| FY2024, ended Dec 31, 2024 | 202M |
| FY2025, ended Dec 31, 2025 | 203M |
| Trailing 12 months to Jun 28, 2026 (through Q2 FY2026) | 201M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $593M | $54.8M |
| FY2017, ended Dec 31, 2017 | $300M | $51.1M |
| FY2018, ended Dec 31, 2018 | $248M | $49.3M |
| FY2019, ended Dec 31, 2019 | $527M | $51.9M |
| FY2020, ended Dec 31, 2020 | $211M | $57.6M |
| FY2021, ended Dec 31, 2021 | $458M | $66.7M |
| FY2022, ended Dec 31, 2022 | $389M | $66.0M |
| FY2023, ended Dec 31, 2023 | $265M | $81.0M |
| FY2024, ended Dec 31, 2024 | $494M | $44.4M |
| FY2025, ended Dec 31, 2025 | $0 | $65.5M |
| Trailing 12 months to Jun 28, 2026 (through Q2 FY2026) | $439M | $69.3M |
Valuation
At current price- Market Cap
- $33.1B
- P/E
- 22.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.7×
- Price / Book
- 7.2×
- EV / EBITDA
- 14.1×
Growth
Trailing 12 months- Revenue (TTM)
- $12.2B
- Revenue Growth YoY
- 7.7%
- Revenue CAGR 3Y
- 3.9%
- Revenue CAGR 5Y
- 7.5%
- EPS Growth YoY
- —. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- −2.7%
Profitability
Trailing 12 months- Gross Margin
- 38.4%
- Operating Margin
- 17.8%
- Net Margin
- 12.2%
- FCF Margin
- 18.3%
- Return on Equity
- 32.8%
Earnings
Trailing 12 months- Net Income
- $1.49B
- EPS (diluted)
- —
- EBITDA
- $2.69B
- Operating Income
- $2.16B
Balance Sheet
As of Jun 28, 2026- Cash and cash equivalents
- $791M
- Total Debt
- $5.61B
- Net Debt
- $4.82B
- Total Assets
- $14.0B
- Total Liabilities
- $9.41B
- Shareholders' Equity
- $4.56B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $2.66B
- Capital Expenditure
- $428M
- Free Cash Flow
- $2.23B
Dividends and risk
Last 12 months- Dividend Yield
- 3.5%
- Dividend / Share
- $5.73
- Beta (5Y)
- 0.10
Every ratio is calculated from the company’s reported figures.